Successful treatment of systemic lupus erythematosus with IgM-enriched immunoglobulins;Erfolgreiche behandlung des systemischen lupus erythematodes mit IgM- angereicherten immunglobulinen

Hautarzt

Volumn 51, Issue 6, 2000, Pages 416-418

  Enk, Alexander H ^a   Knop, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Immunoglobulins; Lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN M; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034119991     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051143     Document Type: Article

References (8)

1. Christian CL (1987) Etiologic hypotheses for systemic lupus erythematosus. In:Lahita RG Systemic lupus erythematosus. Wiley, New York, pp 65-79
2. Kaveri SJ, Dietrich G, Hurez V, Kazatchkine MD (1991) Intravenous immunoglobulins in the treatment of autoimmune diseases. Clin Explmmunol 86:192-198
3. Koffler D (1987) Current perspectives on the immunology of systemic lupus erythematosus. Arthritis Rheum 25:721-910
4. Mills JA (1994) Systemic lupus erythematosus. N Engl J Med 330:1871-1879
5. Schmidt K,Westenberger-Treumann M, Stadler R (1994) Hochdosierte intravenöse Gammaglobulin-Therapie bei juveniler Dermatomyositis. Hautarzt 45:854-857
6. Schroeder JO, Euler HH, Löffler H (1987) Synchronization of plasmapheresis and pulse cyclophosphamide in severe lupus erythematosus. Ann Intern Med 107:344-346
7. Tridandapani S, Kelley T, Cooney D, Pradhan M, Coggeshall KM (1997) Negative signalling in B cells: SHIP Grbs Shc. Immunol Today 18:424-427
8. Winchester RJ, Lahita RG (1987) Genetic susceptibility to systemic lupus erythematosus. In:Lahita RG (ed) Systemic lupus erythematosus. Wiley, New York, pp 291-304